Silo Pharma Issues 150,000 Shares to Acquire Software Assets
Silo Pharma, Inc. (SILO) has agreed to acquire software and related intellectual property assets from Larry King. Under the asset purchase agreement signed on October 13, 2026, the company issued 150,000 shares of common stock as consideration for the technology holdings. Shares of Silo Pharma traded down 1.64% to $1.20 following the disclosure.
The deal allows Silo Pharma to gain ownership of new software assets while preserving cash by using equity for the transaction. To limit immediate share sales on the open market, the newly issued stock is subject to a lock-up period of up to 12 months. However, the restriction may end earlier in the event of a change in control or if the company grants written consent. The contract also contains standard indemnities and legal protections against potential third-party intellectual property claims.
Investors will be watching how Silo Pharma integrates the newly acquired software into its existing operations. Market participants will also monitor whether the company maintains the full 12-month lock-up restriction on the 150,000 issued shares or grants early release, as well as any operational benefits outlined in future updates.
Key points
- Silo Pharma, Inc. (SILO) entered an agreement on October 13, 2026, to acquire software and related intellectual property from Larry King.
- The company funded the acquisition by issuing 150,000 shares of common stock to the counterparty.
- The newly issued shares are subject to a lock-up period of up to 12 months, which may end earlier upon a change in control or written consent.
- The agreement includes standard legal covenants, representations, and protections against third-party intellectual property claims.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
How did Silo Pharma pay for the software acquisition?
Silo Pharma paid for the software and related intellectual property assets by issuing 150,000 shares of common stock to Larry King.
How long is the lock-up period on the issued Silo Pharma shares?
The shares are subject to a lock-up of up to 12 months, though the restriction can end sooner if there is a change in control or if Silo Pharma provides written consent.
When was the agreement between Silo Pharma and Larry King signed?
The asset purchase agreement was signed and became effective on October 13, 2026.